1.     Hsieh YC, Wu PS, Lin YT, Huang YH, Hou MC, Lee KC, and Lin HC. (Pro)renin receptor inhibition attenuated liver steatosis, inflammation and fibrosis in mice with steatohepatitis. FASEB J. (202208 accepted)

2.     Hsieh YC, Lee KC, Lei HJ, Lan KH, Huo TI, Lin YT, Chan CC, Schnabl B, Huang YH, Hou MC, Lin HC. (Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway. Cell Mol Gastroenterol Hepatol. 2021;12(3):813-838

3.     Hsieh YC, Joo SK, Koo BK, Lin HC, Lee DH, Chang MS, Park JH, So YH, Kim W. Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression. Clin Gastroenterol Hepatol. 2022 Jan 31;S1542-3565(22)00074-X. doi: 10.1016/j.cgh.2022.01.020.

4.     Hsieh YC, Lee KC, Wu PS, Huo TI, Huang YH, Hou MC, Lin HC. Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury. Cells. 2021 Jun 21;10(6):1562. doi: 10.3390/cells10061562.

5.     Hsieh YC, Joo SK, Koo BK, Lin HC, Kim W. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2021 Mar;41(3):494-504.